Comparative Efficacy, Safety and Immunogenicity Study of Etanercept and Enbrel

NCT04079374 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

160

Enrollment

INDUSTRY

Sponsor class

Conditions

Rheumatoid Arthritis

Interventions

DRUG: Etanercept
DRUG: Enbrel

Sponsor

Joint Stock Company "Farmak"

Collaborators

[object Object]